Fundraising Fox
/People
Sign in

Matt Cohen

Investor

Managing Partner at OUP (Osage University Partners) · Board director at Alphina Therapeutics

Philadelphia, Pennsylvania

Writes $5M – $10M checks · typically $7.5M

Find your path to Matt

87 people in our graph can introduce you to Matt.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Rosie Barnett to introduce you to Matt

You →Rosie · together at Immventionthera (2025–2026) →Matt

Ask Jamie Chen to introduce you to Matt

You →Jamie · 2 people · together at Immventionthera →Matt

Ask Sam Okafor to introduce you to Matt

You →Sam · 7 people · together at University of Pennsylvania School of Medicine →Matt

Sign up to find every way you can get introduced to Matt

  • Your email: the people you already email who know Matt
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Matt
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Matt Cohen is Managing Partner at Osage University Partners, a venture capital firm investing in innovative technologies derived from university research. He previously worked as a management consultant on projects spanning growth strategy, portfolio prioritization, commercialization planning, and commercial due diligence across multiple industries. Cohen has extensive knowledge of vaccine, immunologic, biologic, and small molecule therapeutic approaches in U.S., European, Brazilian, and Asian markets, with investments in numerous biotechnology companies including PMV Pharmaceuticals, Kura Oncology, Biohaven Pharma, Beam Therapeutics, and Sana Biotechnology.

Contact· self-published, not guessed

Board director at Alphina Therapeutics

Intro paths

→

In turn, Matt can intro founders to Alphina Therapeutics's investors below.

Alphina Therapeutics's investors · 4

Canaan PartnersStamford · $500K – $20M checks · since 2026Connecticut InnovationsNew Haven · $500K – $2M checksHighCape CapitalWestportOUP (Osage University Partners)Bala Cynwyd · $1M – $20M checks

Experience

  1. Osage University Partners (OUP)Managing Partnercurrent2022 — presentBala-Cynwyd, Pennsylvania, United States
  2. Osage University Partners (OUP)Partner2019 — 2022
  3. Osage University Partners (OUP)Principal2016 — 2018Bala Cynwyd, Pennsylvania
  4. Osage University Partners (OUP)Senior Associate2013 — 2016Bala Cynwyd, Pennsylvania
  5. IMMvention Therapeutix, Inc.Board Membercurrent2020 — present
  6. L.E.K. ConsultingConsultant2011 — 2013Greater New York City Area
  7. L.E.K. ConsultingSenior Life Sciences Specialist2012 — 2013Greater New York City Area
  8. L.E.K. ConsultingLife Sciences Specialist2011 — 2012Greater New York City Area
  9. Penn Graduate Consulting GroupCo-President2010 — 2011University of Pennsylvania
  10. Penn Biotech GroupProject Manager / Life Sciences Consultant2010

Skills & more

Lifesciences18Management Consulting9Biotechnology17Financial Modeling4Molecular Biology5Pharmaceutical Industry3Business Strategy4Strategic Consulting2Data Analysis2Market Research5Strategy14Biomedical Engineering2
+4 moreHealthcareOncologyDue DiligenceLife Sciences

From Matt's professional profile.

Colleagues at OUP (Osage University Partners)

Ajay Rayasam
Principal at Osage University Partners
Allen Chen
Principal at Osage University Partners
Anna Turetsky
General Partner, PxB Fund at OUP (Osage University Partners)
Beth Grafstrom
Senior Vice President at OUP (Osage University Partners)
Britt Kennett
Senior Executive Assistant at OUP (Osage University Partners)
Brittany de Kouchkovsky
Director, University Relations at Osage University Partners
Chris Nawalinski
Fund Accountant at OUP (Osage University Partners)
Claudia Dunnous
Chief Financial Officer at OUP (Osage University Partners)

Network1

Ajay Rayasam
Principal at Osage University Partners

Investors connected to Matt in public investor directories — a warm-intro map.

Frequently asked questions

Who is Matt Cohen?
Matt Cohen is Managing Partner at Osage University Partners, a venture capital firm investing in innovative technologies derived from university research. He previously worked as a management consultant on projects spanning growth strategy, portfolio prioritization, commercialization planning, and commercial due diligence across multiple industries. Cohen has extensive knowledge of vaccine, immunologic, biologic, and small molecule therapeutic approaches in U.S., European, Brazilian, and Asian markets, with investments in numerous biotechnology companies including PMV Pharmaceuticals, Kura Oncology, Biohaven Pharma, Beam Therapeutics, and Sana Biotechnology.
Where does Matt Cohen work?
Matt Cohen is Managing Partner at OUP (Osage University Partners) and Board director at Alphina Therapeutics.
What check size does Matt Cohen write?
Matt Cohen typically writes checks of $5M – $10M.
Where did Matt Cohen go to school?
Matt Cohen studied at University of Pennsylvania School of Medicine (PhD, Cell and Molecular Biology); Pennsylvania State University, Eberly College of Science (BS, Microbiology, Statistics).

Same school

Shared employers